Long‐term outcome of juvenile idiopathic arthritis following a placebo‐controlled trial: sustained benefits of early sulfasalazine treatment

OBJECTIVES: A previous 24‐week randomised trial demonstrated that sulfasalazine (SSZ) treatment was superior to placebo (PLAC) in suppressing disease activity in patients with oligo‐ and polyarticular onset juvenile idiopathic arthritis (JIA). The current study determines the long‐term outcome of th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: van Rossum, Marion A J, van Soesbergen, Renée M, Boers, Maarten, Zwinderman, Aeilko H, Fiselier, Theo J W, Franssen, Marcel J A M, Cate, Rebecca ten, van Suijlekom‐Smit, Lisette W A, Wulffraat, Nico M, van Luijk, Wilma H J, Oostveen, Johanna C M, Kuis, Wietse, Dijkmans, Ben A C
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2007
Pynciau:
Extended Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2111611/
https://ncbi.nlm.nih.gov/pubmed/17491099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.064717
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg